BIOSECURE Act 2025 update: what it means for biopharma outsourcing and what to do now
Publication: Pharmaceutical Technology Focus
Cell line development: faster path to a stable master cell bank
Cell line development is a critical early step in biologics manufacturing. For monoclonal antibodies and other therapeutic proteins, the quality of the master cell bank determines not only expression levels but also long-term process stability, regulatory confidence, and downstream scalability.
Redefining What’s Possible in Low-Temperature Chemistry
Read how Syngene delivers ultra‑low‑temperature chemistry down to –90 °C with precision, safety, and full GMP scalability. Explore how our cryogenic infrastructure and expertise in sensitive transformations help de‑risk development and open access to complex, otherwise inaccessible chemistries. Discover how advanced thermal control and integrated manufacturing accelerate your most challenging programs.
Partnering for Precision in Small Molecule Drug Substance Development & Manufacturing
Read how Syngene accelerates small‑molecule development with integrated discovery‑to‑commercial capabilities and globally compliant GMP facilities. Explore how advanced process chemistry, analytical depth, and seamless tech transfer de‑risk scale‑up and strengthen manufacturing reliability.